Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST). Known as SU11248, the drug offers patients with advanc
Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase -- from $51.76 to $55.86. This rate of increase was significantly less than the 13.1% increase from 2001 to 2002, and the lowest rate in the past four years. Gene
Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study presented at the American Society of Clinic
Regulations to remove the current ban on advertising certain over the counter (OTC) medicines to the public were laid in Parliament today. Removing these restrictions on promoting non-prescription medicines to the public has the potential to bring real
The Burnham Institute's Jeffrey Smith, Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening techni
America's health insurance plans today reported significant progress in the enrollment of beneficiaries in the Medicare-endorsed prescription drug discount card program. Acknowledging industry efforts, Karen Ignagni, AHIP President and CEO, said that AH
Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthri
Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that's FDA-approved to treat vascular disease, according to a University of Rochester
Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) ha
"This agreement puts in place a process to target Columbus State students who are pursuing health-related careers and, through Pathways Institute Partnership, offer the support, mentoring and career guidance to help them meet their goals. It is anticipated that many of the students will transfer to Ohio University to complete their undergraduate degrees in the colleges of Arts and Sciences, and Health and Human Services, and that several of those interested in attending medical school will apply to the College of Osteopathic Medicine," said Elizabeth Minor, director of the Center for Excellence for Multicultural Medicine at Ohio University.
"This is a great step forward for community college students in having this option to further their college careers," Columbus State Provost Michael Snider said. "This is a phenomenal day in that we are addressing the educational needs of our citizens and their health-care needs, as well."
The agreement builds upon the articulation agreement signed by CSCC and Ohio University in September to allow a seamless transfer of Columbus State students to Ohio University by easing the transfer process and promoting closer coordination of academic courses, programs and degrees offered by both institutions.
The signing creates a formal agreement and partnership consistent with the diversity missions of the colleges and the Center of Excellence for Multicultural Medicine. Program enrollment may begin at CSCC as early as fall 2004. It is anticipated between 20 to 40 students will be involved in the pilot program next fall.
Columbus State Dean of Arts and Sciences David Hockenbery said, "We have big needs in urban and rural education, and this agreement opens doors for students in health care-related fields."
Ohio University Provost Stephen Kopp said, "An interesting part of the impact that higher education has on people is the opportunity to promote and encourage learning every day. Often, it's an impact that can't be assessed until the future when it fully takes root in a person's life. It's when you see the transformation in a person's life over his or her college career and beyond that you realize what a difference a college education makes."
The mission of the College of Osteopathic Medicine is to educate students to become physicians practicing osteopathic medicine in service to the region, the state and beyond. Integral to that mission, the college commits itself to generating and disseminating new knowledge and understanding through research and scholarly activities; serving the health needs of people within the Appalachian region; embracing diversity and public service, with integrity and respect for those served; and emphasizing primary care and improving the well-being of underserved populations.